Yasser F. Hassan, Eman Alzahrani, Roshdy E. Saraya, Mohamed A. Abdel-Lateef, Ehab A. M. El-Shoura, Hany A. Batakoushy, Adel Ehab Ibrahim, Abd-ElAziem Farouk, Mohamed A. A. Abdel-Aal, Baher I. Salman
{"title":"A promising green fluorimetric approach for analysis of edoxaban in real human plasma using green carbon dots decorated with terbium ions","authors":"Yasser F. Hassan, Eman Alzahrani, Roshdy E. Saraya, Mohamed A. Abdel-Lateef, Ehab A. M. El-Shoura, Hany A. Batakoushy, Adel Ehab Ibrahim, Abd-ElAziem Farouk, Mohamed A. A. Abdel-Aal, Baher I. Salman","doi":"10.1007/s11696-024-03796-6","DOIUrl":null,"url":null,"abstract":"<div><p>An innovative green synthesized carbon quantum dot was decorated with terbium as new fluorescent nanoprobes (Tb,N@CQDs) and developed as eco-friendliness, water-soluble, cost-effectiveness, and biocompatibility quantum dots for analysis of edoxaban (EDN). A microwave synthesis technique produced environmentally friendly (Tb,N@CQDs) in just 7 min, boasting a high quantum yield of 35.44%. The green synthesized quantum dots were then utilized in the development of a sensor for detecting trace amounts of edoxaban (EDN). EDN is a newly approved anticoagulant medication by the US-FDA for treating deep vein thrombosis (DVT) in patients initially treated with a parenteral anticoagulant for 5–10 days. The introduction of EDN resulted in a gradual decrease in the fluorescence intensity of Tb,N@CQDs at 436 nm within the calibration range 30.0 – 350.0 ng mL<sup>−1</sup>. The creative method was validated for bio-analytical applications by FDA standards with a lower limit of quantitation (LOQ) 18.33 ng mL<sup>−1</sup>, demonstrating simplicity, affordability, high sensitivity, and exceptional selectivity, making it suitable for clinical research. This established method proved effective in quantifying EDN in human plasma with percent of recovery (98.88 ± 2.74), pharmaceutical formulations, and pharmacokinetic studies, showcasing sustainability by incorporating recent evaluation criteria.</p></div>","PeriodicalId":513,"journal":{"name":"Chemical Papers","volume":"79 1","pages":"497 - 510"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Papers","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s11696-024-03796-6","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0
Abstract
An innovative green synthesized carbon quantum dot was decorated with terbium as new fluorescent nanoprobes (Tb,N@CQDs) and developed as eco-friendliness, water-soluble, cost-effectiveness, and biocompatibility quantum dots for analysis of edoxaban (EDN). A microwave synthesis technique produced environmentally friendly (Tb,N@CQDs) in just 7 min, boasting a high quantum yield of 35.44%. The green synthesized quantum dots were then utilized in the development of a sensor for detecting trace amounts of edoxaban (EDN). EDN is a newly approved anticoagulant medication by the US-FDA for treating deep vein thrombosis (DVT) in patients initially treated with a parenteral anticoagulant for 5–10 days. The introduction of EDN resulted in a gradual decrease in the fluorescence intensity of Tb,N@CQDs at 436 nm within the calibration range 30.0 – 350.0 ng mL−1. The creative method was validated for bio-analytical applications by FDA standards with a lower limit of quantitation (LOQ) 18.33 ng mL−1, demonstrating simplicity, affordability, high sensitivity, and exceptional selectivity, making it suitable for clinical research. This established method proved effective in quantifying EDN in human plasma with percent of recovery (98.88 ± 2.74), pharmaceutical formulations, and pharmacokinetic studies, showcasing sustainability by incorporating recent evaluation criteria.
以铽作为新型荧光纳米探针(Tb,N@CQDs)修饰绿色合成碳量子点,并将其作为生态友好、水溶性、成本效益和生物相容性好的量子点用于分析依多沙班(EDN)。采用微波合成技术,仅需7分钟即可生产出环境友好的(Tb,N@CQDs),量子产率高达35.44%。绿色合成量子点随后被用于检测痕量伊多沙班(EDN)的传感器的开发。EDN是美国fda新批准的一种抗凝药物,用于治疗最初接受肠外抗凝治疗5-10天的深静脉血栓(DVT)患者。EDN的引入导致Tb,N@CQDs在436 nm处的荧光强度逐渐降低,校准范围为30.0 - 350.0 ng mL−1。该方法通过FDA标准验证,定量下限(LOQ)为18.33 ng mL−1,具有简便、经济、高灵敏度和卓越的选择性,适用于临床研究。结果表明,该方法可有效定量测定人血浆中EDN,回收率(98.88±2.74),适用于药物配方和药代动力学研究,并结合最新评价标准,具有可持续性。
Chemical PapersChemical Engineering-General Chemical Engineering
CiteScore
3.30
自引率
4.50%
发文量
590
期刊介绍:
Chemical Papers is a peer-reviewed, international journal devoted to basic and applied chemical research. It has a broad scope covering the chemical sciences, but favors interdisciplinary research and studies that bring chemistry together with other disciplines.